Switch to:
More From Other Websites
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
Sanofi and Regeneron Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
Midday movers: Hess, Twitter, Valero Eneregy & More Jul 30 2014
Amgen Restructuring Plan, Q2 Earnings Send Stock Up Jul 30 2014
Regeneron shares jump after cholesterol drug meets test goals Jul 30 2014
Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
8:01 am Sanofi-Aventis and Regeneron (REGN) report positive... Jul 30 2014
Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
[video] Lucy Beats Greek Hero Hercules At Box Office Debut Jul 28 2014
Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United... Jul 22 2014
Salix-Pharming's Ruconest Gets FDA Nod for HAE Jul 18 2014
InterMune's (ITMN) Esbriet Gets Breakthrough Designation Jul 18 2014
3 Stocks Pushing The Drugs Industry Lower Jul 17 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide